Daily Target 2X Long HIMS ETF
HIMZ
NASDAQ Global Select- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Defiance Daily Target 2X Long HIMS ETF (HIMZ) is an exchange-traded fund that seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health Inc. (NYSE: HIMS), prior to fees and expenses. The fund employs financial derivatives including swap agreements and options on HIMS common stock, United States Treasury bills, and cash equivalents to achieve its targeted leverage; it rebalances daily and is designed for short-term trading rather than long-term holding due to compounding effects and volatility decay. Launched on March 12, 2025, and domiciled in the United States, HIMZ trades on the Nasdaq and is issued by Defiance ETFs LLC, with Tidal Investments LLC serving as investment adviser. Operated by Defiance ETFs, founded in 2018 and headquartered in Miami, Florida, the fund targets sophisticated investors seeking amplified exposure to Hims & Hers Health, a telehealth platform providing personalized health and wellness products such as treatments for hair loss, sexual health, mental health, dermatology, and weight management via websites and mobile applications. HIMZ focuses exclusively on the healthcare providers and services industry through its linkage to HIMS, which serves consumer markets in the United States; the fund itself maintains U.S.-centric operations with no direct international geographic footprint beyond the NYSE-listed underlying security. In a major recent development, Defiance ETFs launched HIMZ on March 13, 2025, alongside the companion RKLX ETF providing 2X leveraged exposure to Rocket Lab USA Inc., expanding its lineup of single-stock leveraged ETFs that enable margin-free tactical trading in high-growth names. As of late 2025, the fund manages approximately $186 million in net assets with a net expense ratio of 1.29%, reflecting rapid inflows amid volatility in the HIMS stock; top holdings include multiple total return swaps on HIMS shares from counterparties such as BMO, Marex, Cantor, and Nomura, alongside Treasury bills comprising about 33% of assets. No subsequent acquisitions, partnerships, funding rounds, or product expansions for HIMZ have been reported in the past 1-2 years, underscoring its status as a newly introduced leveraged instrument in Defiance's thematic and income-focused ETF portfolio.